Bibliographic Details
| Title: |
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. |
| Authors: |
Cohen SB (AUTHOR), Emery P (AUTHOR), Greenwald MW (AUTHOR), Dougados M (AUTHOR), Furie RA (AUTHOR), Genovese MC (AUTHOR), Keystone EC (AUTHOR), Loveless JE (AUTHOR), Burmester G (AUTHOR), Cravets MW (AUTHOR), Hessey EW (AUTHOR), Shaw T (AUTHOR), Totoritis MC (AUTHOR), REFLEX Trial Group (CORPORATE AUTHOR) |
| Source: |
Arthritis & Rheumatism. Sep2006, Vol. 54 Issue 9, p2793-2806. 14p. |
| Database: |
Academic Search Ultimate |
